The application of proteomic technologies to clinical specimens has the potential to revolutionize the treatment of many diseases. From biomarker discovery and validation to personalized therapies, proteomic techniques allow a greater understanding of the dynamic processes involved in disease, increasing the power of prediction, diagnosis and prognosis.

The editors of Genome Medicine are now accepting submissions of Research, Method, Database, Software and Open Debate manuscripts for an article collection on proteomic applications in medicine, scheduled to begin publication in early 2013. Publication of these articles will be coordinated with a series of commissioned reviews and opinions, edited by Sabine Bahn and Paul Guest (University of Cambridge, UK).

We welcome submissions across the field of proteomics including
• Biomarker discovery, quantification, and validation
• Advances in proteomic profiling technologies
• Tissue proteomics
• Body fluid proteomics
• Stratification and combinatorial therapeutics
• Standardisation of proteomics in the clinic

Please submit using our online system, and indicate in your covering letter that you would like the manuscript to be considered for the proteomic applications in medicine series.

Genome Medicine has a special focus on the latest findings and technologies that impact on the understanding and management of human health and disease, and aims to provide a platform for discussion among scientists and clinicians from diverse disciplines. We offer rapid, high-quality peer review and, in line with our open access policy, all original research articles will be distributed free of charge over the web. For further information, please visit the journal website, or contact editorial@genomemedicine.com.